Tyra Biosciences (TYRA)Director sold ~$309K
Gilla Kaplan, Director at Tyra Biosciences, sold ~$309K of Tyra Biosciences shares.
- ~$309K
- Approx. value · 30K sh @ $10.31
- 60K
- Holds after · shares reported
- Traded
- Jun 12, 2025
- Filed
- Jun 16, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 4, 2025InsiderDirector purchased ~$9.61M of TYRA shares in the open market
- Jun 5, 2025InsiderDirector purchased ~$2.14M of TYRA shares in the open market
- Jun 9, 2025InsiderDirector purchased ~$1.9M of TYRA shares in the open market
- Jun 12, 2025 · this disclosureInsiderDirector sold ~$309K of TYRA shares in the open market
What came next
- Jun 12, 2025InsiderDirector purchased ~$319K of TYRA shares in the open market
- Jun 13, 2025Insider · 2 peopleInsiders: 1 purchase (~$1.2M), 1 sale (~$155K)
- Jun 16, 2025Insider · 2 peopleInsiders: 1 purchase (~$120K), 1 sale (~$71K)
- Jun 17, 2025InsiderDirector sold ~$104 of TYRA shares in the open market
- Jun 18, 2025InsiderDirector sold ~$94K of TYRA shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Tyra Biosciences
For Tyra Biosciences, OQRO holds 5 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TYRA page.
Other recent filings by Gilla Kaplan, Director
- SEC Form 4 at Tyra Biosciences (TYRA)Jun 20, 2025
- SEC Form 4 at Tyra Biosciences (TYRA)Jun 20, 2025
- SEC Form 4 at Tyra Biosciences (TYRA)Jun 16, 2025
- SEC Form 4 at Tyra Biosciences (TYRA)Jun 16, 2025
The full history of Gilla Kaplan, Director is on the profile page.
How this filing works
Other disclosures at Tyra Biosciences
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 13, 2026
- SEC Form 13F-HRMay 15, 2026
Everything OQRO holds on this company is on its TYRA page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
